Literature DB >> 9169790

Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components.

D Delfino1, L Cianci, E Lupis, A Celeste, M L Petrelli, F Curró, V Cusumano, G Teti.   

Abstract

In order to ascertain if Cryptococcus neoformans components can induce interleukin-6 (IL-6) production, we stimulated human whole blood with purified capsular products. Their potencies in stimulating IL-6 release were mannoproteins > galactoxylomannan = glucuronoxylomannan > alpha(1-3)glucan. IL-6 production was tumor necrosis factor alpha independent and required the presence of monocytes and plasma. Since IL-6 can stimulate replication of the human immunodeficiency virus in monocytic cells, these findings may be clinically relevant.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169790      PMCID: PMC175342          DOI: 10.1128/iai.65.6.2454-2456.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Interleukin-6: an overview.

Authors:  J Van Snick
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Cryptococcal infections in patients with acquired immune deficiency syndrome.

Authors:  R H Eng; E Bishburg; S M Smith; R Kapila
Journal:  Am J Med       Date:  1986-07       Impact factor: 4.965

3.  Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans.

Authors:  E S Jacobson; D J Ayers; A C Harrell; C C Nicholas
Journal:  J Bacteriol       Date:  1982-06       Impact factor: 3.490

4.  Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages.

Authors:  M Denis; E O Gregg
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

5.  Tumor necrosis factor-inducing activities of Cryptococcus neoformans components.

Authors:  D Delfino; L Cianci; M Migliardo; G Mancuso; V Cusumano; C Corradini; G Teti
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.

Authors:  R Schindler; J Mancilla; S Endres; R Ghorbani; S C Clark; C A Dinarello
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

7.  The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.

Authors:  T R Kozel; E C Gotschlich
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  Tumor necrosis factor-independent IL-6 production during murine listeriosis.

Authors:  E A Havell; P B Sehgal
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

9.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Authors:  J Van Snick; S Cayphas; A Vink; C Uyttenhove; P G Coulie; M R Rubira; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  24 in total

1.  Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.

Authors:  M Cuzzola; G Mancuso; C Beninati; C Biondo; C von Hunolstein; G Orefici; T Espevik; T H Flo; G Teti
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages.

Authors:  Zong Liang Chang; Dale Netski; Peter Thorkildson; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Role of the Apt1 protein in polysaccharide secretion by Cryptococcus neoformans.

Authors:  Juliana Rizzo; Débora L Oliveira; Luna S Joffe; Guanggan Hu; Felipe Gazos-Lopes; Fernanda L Fonseca; Igor C Almeida; Susana Frases; James W Kronstad; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2013-12-13

4.  Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans.

Authors:  D Pietrella; R Cherniak; C Strappini; S Perito; P Mosci; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.

Authors:  Magdia De Jesus; André Moraes Nicola; Siu-Kei Chow; Ian R Lee; Shuhua Nong; Charles A Specht; Stuart M Levitz; Arturo Casadevall
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

6.  Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.

Authors:  Thomas R Kozel; Stuart M Levitz; Françoise Dromer; Marcellene A Gates; Peter Thorkildson; Guilhem Janbon
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells.

Authors:  Asna A Siddiqui; Robin J Shattock; Thomas S Harrison
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

8.  Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.

Authors:  Carmelo Biondo; Concetta Beninati; Demetrio Delfino; Marco Oggioni; Giuseppe Mancuso; Angelina Midiri; Mauro Bombaci; Giuseppe Tomaselli; Giuseppe Teti
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 9.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

10.  Unusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans.

Authors:  Christian Heiss; Michael L Skowyra; Hong Liu; J Stacey Klutts; Zhirui Wang; Matthew Williams; Deepa Srikanta; Stephen M Beverley; Parastoo Azadi; Tamara L Doering
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.